Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Pregabalin worth it for refractory epilepsy in Spain

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Pregabalin worth it for refractory epilepsy in Spain. Pharmacoecon. Outcomes News 489, 8 (2005). https://doi.org/10.2165/00151234-200504890-00021

    Download citation

    Keywords

    • Outcome News
    • Gabapentin
    • Standard Therapy
    • Randomise Clinical Trial
    • Pregabalin